Teva Pharmaceutical Industries Ltd.
Search documents
OmniAb(OABI) - 2024 Q4 - Earnings Call Presentation
2025-03-18 21:59
Q4 and Full Year 2024 Financial Results & Business Update Nasdaq: OABI March 18, 2025 1 Disclaimer 2 We caution you that this presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, including our financial guidance for 2025, business strategy, our expectations regarding the application of, and the rate and degree of market acceptance of, o ...
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
GlobeNewswire News Room· 2025-03-03 21:30
Company Overview - Teva Pharmaceutical Industries Ltd. is a global pharmaceutical leader with over 120 years of commitment to improving health, operating in 57 markets with a workforce of 37,000 employees [2] Upcoming Events - Richard Francis, Teva's President and CEO, will present at two investor conferences in March 2025: Barclays 27th Annual Global Healthcare Conference on March 11 at 8:00 am ET and Leerink Partners Global Healthcare Conference on March 12 at 8:40 am ET [1][4] Investor Relations - A live webcast of the presentations will be available on Teva's Investor Relations website, with an archived version accessible within 24 hours after the live discussion [1]